Silicon Valley BioTalks is a series of panel discussions for life science professionals looking to streamline their clinical trials. Representatives from leading pharmaceutical, biotechnology and medical device companies share expertise and best practices about the latest hot topics in the industry. 

 Join the group on Linkedin to receive updates on the next session of this event. 

Take a tour of the latest sessions!

• Is EDC becoming a commodity? - April 17^th, 2013

On April 17th 2013, Clinovo hosted the Silicon Valley Biotalks at Onyx Pharmaceuticals in South San Francisco. The panel was composed of: Eric Morrie (Manager, Clinical Programming at Onyx Pharmaceuticals), Dr. Omar Dawood (M.D., M.P.H., Visionary Senior Executive, and Clinical Leader) and Marc Desgrousilliers (Chief Technology Officer
 at Clinovo). The discussion was moderated by Dr. Bob Molinari (Ph.D., CEO of Retrotope Inc. & Partner of MedStars).

• Winning Strategies for Clinical Data Integration - November 8^th, 2012

On November 8th 2012, Clinovo hosted the fifth Silicon Valley Biotalks, hosted by SNR Denton in their Palo Alto offices. The panel was composed of Clinical Data Management experts: Joe Warlow (Janssen Alzheimer Immunotherapy, Director of Clinical Data Management), Lauren Intagliata (Genomic Health, Associate Director of Clinical Data Management) and Chito Hernandez (Elan Pharmaceuticals, Vice President of Biometrics and Information Management).  The panel was moderated by Wessam Sonbol (Clinovo, Senior Data Management Study Lead | Founder of VOXCE). Read the extracts.

• FDA Submission: The New Rules - June 6^th, 2012

On June 6th 2012, Clinovo hosted the fourth Silicon Valley Biotalks, hosted by CapGemini in their South San Francisco offices. The panel was composed of industry experts with up to 20 years experience in regulatory affairs: Dr. Urte Gayko (Nodality, VP of Regulatory and Clinical Affairs), Dr. Christine Conroy (Affymax, VP of Regulatory Affairs and GCP Compliance) and Dr. Sandra Nino-Siddens (Geron Corporation) Executive Director,Regulatory Affairs). The panel was moderated by Dr. Anne-Marie Duliege (Affymax, Chief Medical Officer). Read the extracts.

• How CDISC standards streamline clinical trials - March 7^th, 2012

On March 7th 2012, Clinovo hosted the third Silicon Valley Biotalks, hosted by SNR Denton in their Palo Alto offices. The event welcomed over 60 professionals from the biotechnology and pharmaceuticals industry. The panel was composed of top-tier CDISC experts: John Brega (PharmaStat) CDISC Implementation and eCTD Submissions, Carey Smoak (Roche Molecular) Senior Manager, SAS Programming and CDISC Device Team Leader, Dave Borbas (Jazz Pharmaceuticals) Senior Director, Data Management, and Ale Gicqueau, President & CEO at Clinovo. Read the extracts.

• Run Efficient Clinical Trials With Open Source Technologies- June 29^th, 2011

On June 29th 2011, 50 professionals from the biotechnology and pharmaceuticals industry attended the event. The panel was composed of Victor Chen, Director of Clinical Affairs at Intuitive Surgical, Eric Morrie, Clinical Programming Manager at Abbott Vascular and Ale Gicqueau, President & CEO at Clinovo. Read the extracts.

• Implementing Adaptive Clinical Trials - November 2^nd, 2011

Panelists from leading pharmaceutical and biotechnology companies will address key benefits and limitations of adaptive clinical trials. The panel includes representatives from Theravance, Xenoport, MAP Pharmaceuticals, ARA, Arincal and Clinovo. Leveraging years of experience and expertise, they will explain how adaptive designs help streamline the clinical trial process. Read the extracts.